JLGRX
Price
$88.23
Change
+$0.94 (+1.08%)
Updated
Jul 3 closing price
Net Assets
114.31B
VIGRX
Price
$227.62
Change
+$2.45 (+1.09%)
Updated
Jul 3 closing price
Net Assets
293.94B
Interact to see
Advertisement

JLGRX vs VIGRX

Header iconJLGRX vs VIGRX Comparison
Open Charts JLGRX vs VIGRXBanner chart's image
JPMorgan Large Cap Growth R5
Price$88.23
Change+$0.94 (+1.08%)
VolumeN/A
Net Assets114.31B
Vanguard Growth Index Investor
Price$227.62
Change+$2.45 (+1.09%)
VolumeN/A
Net Assets293.94B
JLGRX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JLGRX vs. VIGRX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLGRX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 294B vs. JLGRX (114B). VIGRX pays higher dividends than JLGRX: VIGRX (0.34) vs JLGRX (0.11). JLGRX was incepted earlier than VIGRX: JLGRX (16 years) vs VIGRX (33 years). JLGRX (0.60) is less costly to investors than VIGRX (0.17). JLGRX is a more actively managed with annual turnover of: 32.00 vs. VIGRX (11.00). JLGRX has a lower initial minimum investment than VIGRX: JLGRX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 15.43 vs. JLGRX (11.63). VIGRX return over 5 years is better than : 115.36 vs. JLGRX (73.13).
JLGRXVIGRXJLGRX / VIGRX
Total Expense Ratio0.540.17318%
Annual Report Gross Expense Ratio0.600.17353%
Fund Existence16 years33 years-
Gain YTD6.7267.72987%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets114B294B39%
Annual Yield % from dividends0.110.3432%
Returns for 1 year11.6315.4375%
Returns for 3 years87.2596.4091%
Returns for 5 years73.13115.3663%
Returns for 10 years136.81312.8144%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABSI2.770.08
+2.97%
Absci Corp
FBIO1.880.05
+2.73%
Fortress Biotech
CORT72.270.93
+1.30%
Corcept Therapeutics
ARQT13.820.06
+0.44%
Arcutis Biotherapeutics
OZKAP16.910.06
+0.36%
Bank OZK